The Safety and Effectiveness of Dual Calcitonin Gene-Related Peptide (CGRP) Therapies for Migraine Treatment: A Focus on Small Molecule Antagonist and Ligand Monoclonal Combinations (P9-12.010)
To assess the effects of dual-CGRP therapy on patients with synergistic use of small molecule antagonists (SMA) and ligand monoclonal antibodies (L-mAb).
Authors
- Ho Hyun Lee
- Edward Weldon (ORCID: https://orcid.org/0000-0002-0493-9344)
- Kyle Ishikawa (ORCID: https://orcid.org/0000-0002-4181-8648)
- Kore Liow (ORCID: https://orcid.org/0000-0001-6452-9227)
- Anson Lee (ORCID: https://orcid.org/0000-0002-8924-6255)
- Julia Jahansooz
- Lana Liquard
- Enrique Carrazana (ORCID: https://orcid.org/0000-0002-4895-8109)
- Anita Cheung
- Reyn Yoshioka
- Man Ian Woo
Institutions
- University of Hawaiʻi at Mānoa (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208371
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00